Abstract
Small molecules including neurotransmitters and peptides are prevented from entry to the CNS by the endothelial cells which line the cerebral microcapillaries. These cells are linked together by tight junctions (Rees and Karnovsky 1976) to form the “so-called” blood-brain-barrier (BBB), To gain entry into the brain, compounds must pass through the BBB traversing the luminal and the abluminal membranes of endothelial cells, by a process that is considered to be receptor mediated and requiring an active transport mechanism (Goldstein and Betz, 1986). Previous studies indicate that one of the desirable features for entry through the BBB is a high lipophilicity (Oldendorph, 1970). Using γ-aminobutyric acid (GABA) as model system, we developed methods for enhancing its brain uptake by as much as 100-fold (Shashoua et al 1984). Cholesteryl, mono and dilinolenoyl glyceride esters of GABA were found to act as prodrugs which, after entry into the CNS and hydrolysis by esterases, released GABA into the central nervous system. In more recent studies we have demonstrated that these methods can also be applied to promote the uptake of dopamine, serotonin and small peptides such as enkephalin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Backus, L., Hesse, G.W., Jacob, J.N., Shashoua, V.E. and Stellar, 1988, Novel GABA agonists depress the reward effect of lateral hypothalamic stimulation in rats, Pharm. Biochem. and Behavior. 30: 657.
Bliss, T.V.P., and Lomo, T., 1973, Long-lasting potentiation of synaptic transmission in the dentate area of the anesthetized rabbit following stimulation of the perforant paths. J. Physiol. London. 232: 331.
Braestrup, C., Mogens, N., and Olsen, C.E., 1980, Urinary and brain ß-carboline-3-carboxylate as potent inhibitors of brain benzodiazepine receptors, Proc Natl. Acad. Sci. USA. 77: 2208.
Breckenridge, R.J., Nicholson, S.H., Nicol, A.J., Suckling, C.J. Leigh, B, and Iversen, L., 1981, Inhibition of [3H] GABA binding to postsynaptic receptors in human cerebrellar synaptic membranes by carboxyl and amino derivatives of GABA, J. Neurochem., 37: 837.
Goldstein, G.W. and Betz, A.L., 1986, The blood brain barrier, Scientific Amer., 255: 74.
Hesse, G.W., Shashoua, V.E., and Jacob, J.N., 1985, Neuropharmacol. Inhibitory effect of cholesteryl γ-aminobutyrate on evoked activity in rat hippocampal slices, Neuropharmacology. 24: 139.
Jacob, J.N., Hesse, G.W., and Shashoua, V.E., 1987, GABA esters 3. Synthesis, brain uptake and pharmacological properties of C-18 glyceryl lipid esters of GABA with varying degrees of unsaturation, J. Med. Chem., 30: 1573.
Jacob, J.N., Shashoua, V.E., Campbell, A., and Baldessarini, R.J., 1985, γ-aminobutyric acid esters 2. Synthesis, brain uptake, and pharmacological properties of lipid esters of γ-aminobutyric esters, J. Med. Chem., 28: 106.
Lynch, G., Schubert P., 1980, the use of vitro brain slices for multidisciplinary studies of synaptic function. Ann. Rev. Neurosci., 3: 1.
McKenzie, G.M., and Hansen, E. L., 1980, GABA agonists dissociate striatal unit activity from drugs induced stereotyped behavior, Neuropharmacol., 19: 957.
Oldendorf, W.H., 1970, Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard, Brain Res., 24: 372.
Reese, T.S., and Karnovsky, M.J., 1967, Fine structural localization of a blood-brain barrier to exogenous peroxidase, J. Cell Biol., 34: 207.
Roberts, E., 1972, An hypothesis suggesting that there is a defect in the GABA system in schizophrenia. Bulletin Neurosci. Res. Prog., 10: 468.
Sakai, M., Swartz, B.E., and Woody, C.D., 1979, Controlled micro release of pharmacological agents: measurements of volume ejected in vitro through fine tipped glass microelectrodes by pressure, Neuropharmacol., 18: 209.
Shashoua, V.E., Jacob, J.N., Ridge, R., Campbell, A., and Baldessarini, R, J., 1984, γ-aminobutyric esters. 1. Synthesis, brain uptake, and pharmacological of aliphatic and steroid esters of γ-aminobutyric acid, J. Med. Chem., 27: 659.
Stellar, J., Kelley, A.E., and Corbett, D.E., 1983, Effects of peripheral and central dopamine blockade on lateral hypothalamic self-stimulation: Evidence for both reward and motor deficits, Pharmacol. Biochem. Behav., 18: 433.
Warbritton, J.D., Stewart, R.M., and Baldessarini, R.J., 1978, Decreased locomotor activity and attenuation of amphetamine hyperactivity with interventricular infusion of serotonin in the rat, Brain Res., 143: 373.
Wettstein, J.G., and Spealman, R.D., 1986, Behavioral effects of Zopiclone, CL 218, 872 and diazepan in squirrel monkeys: Antagonism by R015-1788 and CGS-8216, J. Pharmacol. Exp. Ther., 238: 522.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Shashoua, V.E. (1992). Procedures for Penetrating the Blood-Brain-Barrier: Studies of γ-Aminobutyric Acid (GABA). In: Meyer, E.M., Simpkins, J.W., Yamamoto, J., Crews, F.T. (eds) Treatment of Dementias. Advances in Behavioral Biology, vol 40. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3432-7_24
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3432-7_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6518-1
Online ISBN: 978-1-4615-3432-7
eBook Packages: Springer Book Archive